EFFICACY OF ADJUVANT 9-WEEKS TRASTUZUMAB IN NODE-NEGATIVE T1A/B HER2-POSITIVE BREAST CANCER

Sendur, M. A.Aksoy, S.Uncu, D.Demir, H.Yuksel, S.Ekinci, A. S.Kaplan, A.2024-04-242024-04-2420140923-75341569-8041https://doi.org/10.1093/annonc/mdu327.44https://hdl.handle.net/11468/1718139th ESMO Congress (ESMO) -- SEP 26-30, 2014 -- Madrid, SPAIN[Abstract Not Available]eninfo:eu-repo/semantics/closedAccess[No Keyword]EFFICACY OF ADJUVANT 9-WEEKS TRASTUZUMAB IN NODE-NEGATIVE T1A/B HER2-POSITIVE BREAST CANCEREFFICACY OF ADJUVANT 9-WEEKS TRASTUZUMAB IN NODE-NEGATIVE T1A/B HER2-POSITIVE BREAST CANCERConference Object25WOS:00034690100016710.1093/annonc/mdu327.44Q1